TTC30A2 Activators
Chemical activators of TTC30A2 employ various biochemical mechanisms to modulate the activity of this protein. Forskolin acts by directly stimulating adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels within the cell. This elevation of cAMP activates protein kinase A (PKA), which can phosphorylate TTC30A2, thereby modulating its activity. Similarly, IBMX increases cAMP levels by inhibiting phosphodiesterases, enzymes responsible for cAMP degradation. The resulting accumulation of cAMP can also activate PKA, which in turn may target TTC30A2 for phosphorylation and activation. PMA operates through a different pathway, activating protein kinase C (PKC), which is known to phosphorylate a wide array of proteins. Through this mechanism, PKC can contribute to the phosphorylation and subsequent activation of TTC30A2.
The rise in intracellular calcium levels is another route through which TTC30A2 activation can occur. Ionomycin facilitates this process by acting as a calcium ionophore, increasing the intracellular concentration of calcium ions. This spike in calcium levels can activate calmodulin-dependent kinases (CaMK), which may then phosphorylate and activate TTC30A2. Thapsigargin also elevates cytosolic calcium by inhibiting the SERCA pump, potentially leading to the activation of CaMK and subsequent phosphorylation of TTC30A2. Additionally, inhibitors of protein phosphatases such as okadaic acid and calyculin A prevent the dephosphorylation of proteins, therefore maintaining TTC30A2 in an active, phosphorylated state. Anisomycin activates stress-activated protein kinases (SAPKs) that can target a range of proteins for phosphorylation, including TTC30A2. Lastly, staurosporine, although generally a kinase inhibitor, can in specific contexts activate certain kinases that phosphorylate proteins such as TTC30A2. Phosphatidic acid and LY294002 can influence mTOR and PI3K/AKT/mTOR pathways, respectively, leading to downstream effects that may include the activation of TTC30A2. U73122 disrupts signaling pathways by inhibiting phospholipase C, which can lead to a compensatory activation of kinases that phosphorylate and activate TTC30A2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-specific inhibitor of phosphodiesterases, which increases cAMP levels by preventing its degradation. Elevated cAMP can activate PKA, which in turn can lead to the phosphorylation and functional activation of TTC30A2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can lead to the phosphorylation of proteins that are in the same pathway or interact with TTC30A2, resulting in its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, leading to the activation of calmodulin-dependent kinase (CaMK), which can phosphorylate and thereby activate TTC30A2. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatase 1 (PP1) and 2A (PP2A), which prevents dephosphorylation of proteins, indirectly maintaining TTC30A2 in a phosphorylated and active state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, similar to okadaic acid, is an inhibitor of PP1 and PP2A, leading to the sustained phosphorylation and activation of proteins, potentially including TTC30A2. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases (SAPKs), which can phosphorylate a range of proteins, possibly including TTC30A2, leading to its activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, which can activate CaMK, potentially resulting in the phosphorylation and activation of TTC30A2. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a non-specific kinase inhibitor, but at low concentrations, it can paradoxically activate certain kinases indirectly. This can lead to the phosphorylation of downstream proteins, including TTC30A2, and thereby its activation. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $106.00 $244.00 $417.00 | ||
Phosphatidic acid can activate mTOR signaling, which is involved in protein synthesis and can lead to the activation of downstream proteins that interact with or are in the same pathway as TTC30A2, resulting in its activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, which paradoxically can lead to the activation of certain protein kinases through feedback loops within the PI3K/AKT/mTOR pathway, potentially resulting in the activation of TTC30A2. | ||||||